B. KOSOVA Et Al. , "Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells," LEUKEMIA & LYMPHOMA , vol.51, no.10, pp.1895-1901, 2010
KOSOVA, B. Et Al. 2010. Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells. LEUKEMIA & LYMPHOMA , vol.51, no.10 , 1895-1901.
KOSOVA, B., Tezcanli, B., Ekiz, H. A., Cakir, Z., SELVİ GÜNEL, N., Dalmizrak, A., ... Kartal, M.(2010). Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells. LEUKEMIA & LYMPHOMA , vol.51, no.10, 1895-1901.
KOSOVA, BUKET Et Al. "Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells," LEUKEMIA & LYMPHOMA , vol.51, no.10, 1895-1901, 2010
KOSOVA, BUKET Et Al. "Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells." LEUKEMIA & LYMPHOMA , vol.51, no.10, pp.1895-1901, 2010
KOSOVA, B. Et Al. (2010) . "Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells." LEUKEMIA & LYMPHOMA , vol.51, no.10, pp.1895-1901.
@article{article, author={BUKET KOSOVA Et Al. }, title={Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells}, journal={LEUKEMIA & LYMPHOMA}, year=2010, pages={1895-1901} }